ABCL
Price
$3.41
Change
-$0.06 (-1.73%)
Updated
Jun 20 closing price
Capitalization
1.02B
51 days until earnings call
ARVN
Price
$7.44
Change
-$0.03 (-0.40%)
Updated
Jun 20 closing price
Capitalization
541.96M
39 days until earnings call
Interact to see
Advertisement

ABCL vs ARVN

Header iconABCL vs ARVN Comparison
Open Charts ABCL vs ARVNBanner chart's image
AbCellera Biologics
Price$3.41
Change-$0.06 (-1.73%)
Volume$8.76M
Capitalization1.02B
Arvinas
Price$7.44
Change-$0.03 (-0.40%)
Volume$2.15M
Capitalization541.96M
ABCL vs ARVN Comparison Chart in %
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. ARVN commentary
Jun 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and ARVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 22, 2025
Stock price -- (ABCL: $3.41 vs. ARVN: $7.44)
Brand notoriety: ABCL and ARVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 173% vs. ARVN: 80%
Market capitalization -- ABCL: $1.02B vs. ARVN: $541.96M
ABCL [@Biotechnology] is valued at $1.02B. ARVN’s [@Biotechnology] market capitalization is $541.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $333.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileARVN’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ARVN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABCL and ARVN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while ARVN’s TA Score has 7 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • ARVN’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +6.56% price change this week, while ARVN (@Biotechnology) price change was +0.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.57%. For the same industry, the average monthly price growth was +27.78%, and the average quarterly price growth was +14.34%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 12, 2025.

ARVN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.02B) has a higher market cap than ARVN($542M). ABCL YTD gains are higher at: 16.382 vs. ARVN (-61.189). ARVN has higher annual earnings (EBITDA): -89.3M vs. ABCL (-211.2M). ARVN has more cash in the bank: 954M vs. ABCL (605M). ARVN has less debt than ABCL: ARVN (10.5M) vs ABCL (67.8M). ARVN has higher revenues than ABCL: ARVN (427M) vs ABCL (23.1M).
ABCLARVNABCL / ARVN
Capitalization1.02B542M188%
EBITDA-211.2M-89.3M237%
Gain YTD16.382-61.189-27%
P/E RatioN/AN/A-
Revenue23.1M427M5%
Total Cash605M954M63%
Total Debt67.8M10.5M646%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
86
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLARVN
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 6 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 12 days ago
76%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARFFX15.950.04
+0.25%
Ariel Focus Investor
TRMSX21.18-0.04
-0.19%
T. Rowe Price Mid-Cap Index I
PSIAX44.37-0.10
-0.22%
PGIM Quant Solutions Large-Cap Index A
USAUX68.62-0.49
-0.71%
Victory Aggressive Growth
MRSIX26.23-0.20
-0.76%
MFS Research International I

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.73%
CRSP - ABCL
62%
Loosely correlated
-0.41%
RXRX - ABCL
58%
Loosely correlated
-1.57%
ABSI - ABCL
57%
Loosely correlated
+1.45%
BEAM - ABCL
56%
Loosely correlated
-1.35%
VCYT - ABCL
56%
Loosely correlated
-1.60%
More